Denali Therapeutics Inc. - Filer Information

Symbol
DNLI on Nasdaq
Entity
Company
CIK
0001714899
EIN
463872213
Business address
161 Oyster Point Blvd., 94080 South San Francisco, CA
Phone
(650) 866-8547
State of incorporation
DE
Fiscal year end
December 31
Category
Large accelerated filer
All SEC filings
View on sec.gov
Get insider transactions for this issuer
Get financial reports for this company